SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-09-066238
Filing Date
2009-11-20
Accepted
2009-11-20 15:40:21
Documents
5
Period of Report
2009-11-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a09-34014_18k.htm 8-K 42261
2 EX-5.1 a09-34014_1ex5d1.htm EX-5.1 7982
3 EX-10.2 a09-34014_1ex10d2.htm EX-10.2 26298
4 EX-99.1 a09-34014_1ex99d1.htm EX-99.1 16745
5 GRAPHIC g340141kgi001.jpg GRAPHIC 2129
  Complete submission text file 0001104659-09-066238.txt   98055
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 7000 SHORELINE COURT SUITE 270 SO. SAN FRANCISCO CA 94080 2062862501
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16614 | Film No.: 091198652
SIC: 2834 Pharmaceutical Preparations